Adams Clinical
Private Company
Funding information not available
Overview
Adams Clinical operates as a specialized clinical research site organization (CRO site network) dedicated to neuroscience, psychiatry, and ophthalmology. With six sites across major metro areas in New York, Massachusetts, Pennsylvania, and Texas, it leverages a centralized operational model to deliver consistent quality and accelerate study timelines for pharmaceutical sponsors. The company is privately held, generates revenue through clinical trial services, and focuses on building participant trust and access. Its long-standing presence since 1993 provides deep therapeutic expertise and operational stability in a complex trial environment.
Technology Platform
Integrated network of six clinical research sites with standardized operational processes, centralized management, and geographic diversity designed to accelerate patient recruitment and ensure consistent, high-quality trial execution for sponsors in neuroscience and ophthalmology.
Opportunities
Risk Factors
Competitive Landscape
Adams Clinical competes with other independent clinical research site networks, the site networks of large global Contract Research Organizations (CROs), and academic medical centers. Its differentiation is its deep, long-standing specialization in psychiatry and neurology trials and its controlled network model offering consistency and speed. Competitors range from large, diversified players like ICON and Parexel to other focused CNS site networks.